Theriva Biologics, Inc. Debt Securities, Held-to-maturity, Sold, Realized Gain (Loss), Excluding Other-than-temporary Impairment
Theriva Biologics, Inc. (TOVX) reported Debt Securities, Held-to-maturity, Sold, Realized Gain (Loss), Excluding Other-than-temporary Impairment of $0 for the 12-month period ending 2012-12-31, per its 10-K filed 2013-04-16.
Discontinued › Income Statement › Other Income
us-gaap:HeldtomaturitySecuritiesSoldSecurityRealizedGainLossExcludingOtherThanTemporaryImpairments · last filed 2013-04-16
- Theriva Biologics, Inc. debt securities, held-to-maturity, sold, realized gain (loss), excluding other-than-temporary impairment for fiscal 2012 was $0.00.
- Theriva Biologics, Inc. debt securities, held-to-maturity, sold, realized gain (loss), excluding other-than-temporary impairment for fiscal 2011 was -$20.00K.
- Theriva Biologics, Inc. debt securities, held-to-maturity, sold, realized gain (loss), excluding other-than-temporary impairment for fiscal 2010 was $0.00.
| Period end | Debt Securities, Held-to-maturity, Sold, Realized Gain (Loss), Excluding Other-than-temporary Impairment 12 month | Debt Securities, Held-to-maturity, Sold, Realized Gain (Loss), Excluding Other-than-temporary Impairment 12 month as first filed |
|---|---|---|
| 2012-12-31 | $0.00 10-K · filed 2013-04-16 | |
| 2011-12-31 | -$20.00K 10-K · filed 2013-04-16 | $20.00K 10-K · filed 2012-03-30 |
| 2010-12-31 | $0.00 10-K/A · filed 2012-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |